{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T01:33:05Z","timestamp":1790127185847,"version":"4.0.1"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1016\/j.jaut.2014.07.005","type":"journal-article","created":{"date-parts":[[2014,8,27]],"date-time":"2014-08-27T01:00:49Z","timestamp":1409101249000},"page":"15-20","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":54,"special_numbering":"C","title":["Epitope-based approaches to a universal influenza vaccine"],"prefix":"10.1016","volume":"54","author":[{"given":"Tanya","family":"Gottlieb","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamar","family":"Ben-Yedidia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaut.2014.07.005_bib1","series-title":"Orthomyxoviruses: influenza","year":"1998"},{"issue":"5853","key":"10.1016\/j.jaut.2014.07.005_bib2","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/296115a0","article-title":"Molecular mechanism of variation in influenza viruses","volume":"296","author":"Webster","year":"1982","journal-title":"Nature"},{"key":"10.1016\/j.jaut.2014.07.005_bib3","series-title":"Receptor specificity, host-range, and pathogenicity of influenza viruses","year":"2006"},{"issue":"28C","key":"10.1016\/j.jaut.2014.07.005_bib4","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.coi.2014.02.005","article-title":"Eliciting broadly protective antibody responses against influenza","volume":"12","author":"Kirchenbaum","year":"2014","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.jaut.2014.07.005_bib5","unstructured":"http:\/\/www.cdc.gov\/flu\/about\/qa\/vaccineeffect.htm."},{"issue":"8","key":"10.1016\/j.jaut.2014.07.005_bib6","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.vaccine.2005.08.105","article-title":"Antibody response to influenza vaccination in the elderly: a quantitative review","volume":"24","author":"Goodwin","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.jaut.2014.07.005_bib7","unstructured":"www.cdc.gov\/flu\/about\/qa\/flushot.htm."},{"issue":"9492","key":"10.1016\/j.jaut.2014.07.005_bib8","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/S0140-6736(05)67339-4","article-title":"Efficacy and effectiveness of influenza vaccines in elderly people: a systematic review","volume":"366","author":"Jefferson","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.jaut.2014.07.005_bib9","unstructured":"www.cidrap.umn.edu\/cidrap\/content\/influenza\/panflu\/news\/may2110vaxprod.html."},{"key":"10.1016\/j.jaut.2014.07.005_bib10","unstructured":"www.cidrap.umn.edu\/news-perspective\/2012\/11\/fda-clears-first-cell-based-flu-vaccine."},{"key":"10.1016\/j.jaut.2014.07.005_bib11","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/j.0818-9641.2004.01272.x","article-title":"Vaccine adjuvants: current state and future trends","volume":"82","author":"Petrovsky","year":"2004","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.jaut.2014.07.005_bib12","unstructured":"http:\/\/www.cdc.gov\/vaccinesafety\/Concerns\/h1n1_narcolepsy_pandemrix.html."},{"key":"10.1016\/j.jaut.2014.07.005_bib13","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/1471-2334-9-129","article-title":"Potential for a global dynamic of influenza A (H1N1)","volume":"9","author":"Flahault","year":"2009","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jaut.2014.07.005_bib14","unstructured":"www.phe.gov\/Preparedness\/mcm\/H1N1-retrospective\/Documents\/H1N1-retrospective.pdf."},{"key":"10.1016\/j.jaut.2014.07.005_bib15","unstructured":"www.examiner.com\/x-29691-Boulder-Healthy-Living-Examiner\u223cy2010m1d4-H1N1-Swine-Flu-Vaccine-Update-European-countries-selling-excess-H1N1-swine-flu-vaccine."},{"key":"10.1016\/j.jaut.2014.07.005_bib16","unstructured":"www.cdc.gov\/flu\/professionals\/acip\/2013-summary-recommendations.html."},{"key":"10.1016\/j.jaut.2014.07.005_bib17","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/S1473-3099(08)70232-9","article-title":"Stockpiling prepandemic influenza vaccines: a new cornerstone of pandemic preparedness plans","volume":"8","author":"Jennings","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.jaut.2014.07.005_bib18","doi-asserted-by":"crossref","first-page":"5086","DOI":"10.1016\/j.vaccine.2007.03.046","article-title":"The annual impact of seasonal influenza in the US: measuring disease burden and costs","volume":"25","author":"Molinari","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.jaut.2014.07.005_bib19","unstructured":"Keogh-Brown M, McDonald S, Edmunds WJ, Beutels P, Smith RD. The macroeconmic costs of a global influenza pandemic. In press, https:\/\/www.gtap.agecon.purdue.edu\/resources\/download\/3828.pdf."},{"key":"10.1016\/j.jaut.2014.07.005_bib20","doi-asserted-by":"crossref","first-page":"7443","DOI":"10.1016\/j.vaccine.2012.10.025","article-title":"The economic value of a quadrivalent versus trivalent influenza vaccine","volume":"30","author":"Lee","year":"2012","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.jaut.2014.07.005_bib21","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1128\/iai.29.2.654-662.1980","article-title":"Outcome of influenza infection: effect of site of initial infection and heterotypic immunity","volume":"29","author":"Yetter","year":"1980","journal-title":"Infect Immun"},{"issue":"36","key":"10.1016\/j.jaut.2014.07.005_bib22","doi-asserted-by":"crossref","first-page":"4983","DOI":"10.1016\/j.vaccine.2009.05.079","article-title":"Infection of mice with a human influenza A\/H3N2 virus induces protective immunity against lethal infection with influenza A\/H5N1 virus","volume":"27","author":"Kreijtz","year":"2009","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.jaut.2014.07.005_bib23","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.4049\/jimmunol.158.3.1222","article-title":"Mechanisms of heterosubtypic immunity to lethal influenza a virus infection in fully immunocompetent, T cell-depleted, beta2-microglobulin-deficient, and J chain-deficient mice","volume":"158","author":"Epstein","year":"1997","journal-title":"J\u00a0Immunol"},{"issue":"10","key":"10.1016\/j.jaut.2014.07.005_bib24","doi-asserted-by":"crossref","first-page":"e7517","DOI":"10.1371\/journal.pone.0007517","article-title":"Identification of a PA-binding peptide with inhibitory activity against influenza A and B virus replication","volume":"4","author":"Wunderlich","year":"2009","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.jaut.2014.07.005_bib25","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.4049\/jimmunol.1000091","article-title":"Immunity to pre-1950 H1N1 influenza viruses confers cross-protection against the pandemic swine-origin 2009 A (H1N1) influenza virus","volume":"185","author":"Skountzou","year":"2010","journal-title":"J\u00a0Immunol"},{"issue":"15","key":"10.1016\/j.jaut.2014.07.005_bib26","doi-asserted-by":"crossref","first-page":"7662","DOI":"10.1128\/JVI.02444-09","article-title":"Cross-reactive neutralizing antibodies directed against pandemic H1N1 2009 virus are protective in a highly sensitive DBA\/2 mouse influenza model","volume":"84","author":"Boon","year":"2010","journal-title":"J\u00a0Virol"},{"issue":"13","key":"10.1016\/j.jaut.2014.07.005_bib27","doi-asserted-by":"crossref","first-page":"6527","DOI":"10.1128\/JVI.00519-10","article-title":"Cytotoxic T lymphocytes established by seasonal human influenza cross-react against 2009 pandemic H1N1 influenza virus","volume":"84","author":"Tu","year":"2010","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.jaut.2014.07.005_bib28","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0928-8244(03)00009-9","article-title":"N-terminus of M2 protein could induce antibodies with inhibitory activity against influenza virus replication","volume":"35","author":"Liu","year":"2003","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"15","key":"10.1016\/j.jaut.2014.07.005_bib29","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1016\/j.vaccine.2009.02.011","article-title":"A\u00a0universal epitope-based influenza vaccine and its efficacy against H5N1","volume":"27","author":"Adar","year":"2009","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.jaut.2014.07.005_bib30","doi-asserted-by":"crossref","first-page":"4212","DOI":"10.1128\/JVI.02508-09","article-title":"Cytotoxic T cells are the predominant players providing cross-protective immunity induced by {gamma}-irradiated influenza a viruses","volume":"84","author":"Furuya","year":"2010","journal-title":"J\u00a0Virol"},{"issue":"5\u20136","key":"10.1016\/j.jaut.2014.07.005_bib31","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0161-5890(02)00095-0","article-title":"A\u00a0retro-inverso peptide analogue of influenza virus hemagglutinin B-cell epitope 91-108 induces a strong mucosal and systemic immune response and confers protection in mice after intranasal immunization","volume":"39","author":"Ben-Yedidia","year":"2002","journal-title":"Mol Immunol"},{"issue":"4","key":"10.1016\/j.jaut.2014.07.005_bib32","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1084\/jem.164.4.1114","article-title":"Functional analysis of influenza-specific helper T cell clones in\u00a0vivo. T cells specific for internal viral proteins provide cognate help for B cell responses to hemagglutinin","volume":"164","author":"Scherle","year":"1986","journal-title":"J\u00a0Exp Med"},{"issue":"10","key":"10.1016\/j.jaut.2014.07.005_bib33","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1002\/eji.1830101013","article-title":"Cell cooperation in antibody responses to influenza virus. I. Priming of helper T cells by internal components of virion","volume":"10","author":"Russell","year":"1980","journal-title":"Eur J Immunol"},{"issue":"6","key":"10.1016\/j.jaut.2014.07.005_bib34","doi-asserted-by":"crossref","first-page":"627","DOI":"10.2174\/1573406410602060627","article-title":"Current status of short synthetic peptides as vaccines","volume":"2","author":"Hans","year":"2006","journal-title":"Med Chem"},{"issue":"11","key":"10.1016\/j.jaut.2014.07.005_bib35","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.1002\/eji.1830211136","article-title":"Exact prediction of a natural T cell epitope","volume":"21","author":"R\u00f6tzschke","year":"1991","journal-title":"Eur J Immunol"},{"issue":"4","key":"10.1016\/j.jaut.2014.07.005_bib36","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/S0958-1669(97)80066-3","article-title":"Design of peptide and polypeptide vaccines","volume":"8","author":"Ben-Yedidia","year":"1997","journal-title":"Curr Opin Biotechnol"},{"key":"10.1016\/j.jaut.2014.07.005_bib37","doi-asserted-by":"crossref","first-page":"7052","DOI":"10.1128\/JVI.78.13.7052-7060.2004","article-title":"Protection against lethal vaccinia virus challenge in HLA-A2 transgenic mice by immunization with a single CD8+ T-cell peptide epitope of vaccinia and variola viruses","volume":"78","author":"Snyder","year":"2004","journal-title":"J\u00a0Virol"},{"issue":"Pt 6","key":"10.1016\/j.jaut.2014.07.005_bib38","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1099\/0022-1317-80-6-1401","article-title":"Synergistic effect of immunization with a peptide cocktail inducing antibody, helper and cytotoxic T-cell responses on protection against respiratory syncytial virus","volume":"80","author":"Hsu","year":"1999","journal-title":"J\u00a0Gen Virol"},{"issue":"12","key":"10.1016\/j.jaut.2014.07.005_bib39","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1002\/psc.896","article-title":"Viral peptide immunogens: current challenges and opportunities","volume":"13","author":"Azizi","year":"2007","journal-title":"J\u00a0Pept Sci"},{"issue":"17\u201318","key":"10.1016\/j.jaut.2014.07.005_bib40","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1016\/S0264-410X(02)00115-9","article-title":"Safety, tolerability and immunogenicity of new formulations of the plasmodium falciparum malaria peptide vaccine spf66 combined with the immunological adjuvant QS-21","volume":"20","author":"Kashala","year":"2002","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.jaut.2014.07.005_bib41","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1086\/315871","article-title":"Synthetic malaria peptide vaccine elicits high levels of antibodies in vaccinees of defined HLA genotypes","volume":"182","author":"Nardin","year":"2000","journal-title":"J\u00a0Infect Dis"},{"issue":"6","key":"10.1016\/j.jaut.2014.07.005_bib42","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S0161-5890(01)00081-5","article-title":"Peptide vaccines against Hepatitis B virus: from animal model to human studies","volume":"38","author":"Engler","year":"2001","journal-title":"Mol Immunol"},{"issue":"7","key":"10.1016\/j.jaut.2014.07.005_bib43","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1089\/aid.2006.22.684","article-title":"New cd4+ and cd8+ T cell responses induced in chronically hiv type-1-infected patients after immunizations with an HIV type 1 lipopeptide vaccine","volume":"22","author":"Gahery","year":"2006","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"15","key":"10.1016\/j.jaut.2014.07.005_bib44","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1097\/00002030-199910220-00002","article-title":"HIV-specific immunity following immunization with HIV synthetic envelope peptides in asymptomatic HIV-infected patients","volume":"13","author":"Pinto","year":"1999","journal-title":"AIDS"},{"issue":"1","key":"10.1016\/j.jaut.2014.07.005_bib45","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1080\/08830180802593540","article-title":"Neutralizing anti-influenza virus monoclonal antibodies: therapeutics and tools for discovery","volume":"28","author":"Martinez","year":"2009","journal-title":"Int Rev Immunol"},{"issue":"3","key":"10.1016\/j.jaut.2014.07.005_bib46","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/nsmb.1566","article-title":"Structural and functional bases for broad-spectrum neutralization of avian and human influenza a viruses","volume":"16","author":"Sui","year":"2009","journal-title":"Nat Struct Mol Biol"},{"issue":"2","key":"10.1016\/j.jaut.2014.07.005_bib47","doi-asserted-by":"crossref","first-page":"e1000796","DOI":"10.1371\/journal.ppat.1000796","article-title":"Broadly protective monoclonal antibodies against H3 influenza viruses following sequential immunization with different hemagglutinins","volume":"6","author":"Wang","year":"2010","journal-title":"PLoS Pathog"},{"issue":"200","key":"10.1016\/j.jaut.2014.07.005_bib48","doi-asserted-by":"crossref","first-page":"200ra114","DOI":"10.1126\/scitranslmed.3006366","article-title":"Vaccine-induced anti-HA2 antibodies promote virus fusion and enhance influenza virus respiratory disease","volume":"5","author":"Khurana","year":"2013","journal-title":"Sci Transl Med"},{"issue":"7178","key":"10.1016\/j.jaut.2014.07.005_bib49","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1038\/nature06528","article-title":"Structural basis for the function and inhibition of an influenza virus proton channel","volume":"451","author":"Stouffer","year":"2008","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.jaut.2014.07.005_bib50","doi-asserted-by":"crossref","first-page":"6644","DOI":"10.1128\/JVI.79.11.6644-6654.2005","article-title":"Influenza type A virus escape mutants emerge in\u00a0vivo in the presence of antibodies to the ectodomain of matrix protein 2","volume":"79","author":"Zharikova","year":"2005","journal-title":"J\u00a0Virol"},{"issue":"1","key":"10.1016\/j.jaut.2014.07.005_bib51","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.bbrc.2009.04.129","article-title":"Monoclonal antibody recognizing SLLTEVET epitope of M2e protein potentialy inhibited the replication of influenza viruses in mdck cells","volume":"385","author":"Wang","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"issue":"11","key":"10.1016\/j.jaut.2014.07.005_bib52","doi-asserted-by":"crossref","first-page":"e48484","DOI":"10.1371\/journal.pone.0048484","article-title":"MHC class I-presented T cell epitopes identified by immunoproteomics analysis are targets for a cross reactive influenza-specific T cell response","volume":"7","author":"Testa","year":"2012","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.jaut.2014.07.005_bib53","doi-asserted-by":"crossref","first-page":"e24626","DOI":"10.1371\/journal.pone.0024626","article-title":"Cross-protective peptide vaccine against influenza A viruses developed in HLA-A*2402 human immunity model","volume":"6","author":"Ichihashi","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jaut.2014.07.005_bib54","unstructured":"www.its-innovation.com\/index.php."},{"issue":"9","key":"10.1016\/j.jaut.2014.07.005_bib55","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1002\/eji.200737254","article-title":"Synthetic multi-epitope peptides identified in silico induce protective immunity against multiple influenza serotypes","volume":"37","author":"Stoloff","year":"2007","journal-title":"Eur J Immunol"},{"issue":"31","key":"10.1016\/j.jaut.2014.07.005_bib56","doi-asserted-by":"crossref","first-page":"4655","DOI":"10.1016\/j.vaccine.2012.04.089","article-title":"Synthetic influenza vaccine (FLU-v) stimulates cell mediated immunity in a double-blind, randomised, placebo-controlled phase I trial","volume":"30","author":"Pleguezuelos","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.jaut.2014.07.005_bib57","unstructured":"http:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT01226758?term=flu+v&rank=2."},{"key":"10.1016\/j.jaut.2014.07.005_bib58","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1093\/intimm\/11.7.1043","article-title":"Intranasal administration of peptide vaccine protects human\/mouse radiation chimera from influenza infection","volume":"11","author":"Ben-Yedidia","year":"1999","journal-title":"Int Immunol"},{"issue":"S9","key":"10.1016\/j.jaut.2014.07.005_bib59","first-page":"20","article-title":"Preparedness ahead of pandemic outbreaks","volume":"11","author":"Gottlieb","year":"2013","journal-title":"BioProcess Int"},{"issue":"15","key":"10.1016\/j.jaut.2014.07.005_bib60","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1016\/j.vaccine.2009.02.011","article-title":"A\u00a0universal epitope-based influenza vaccine and its efficacy against H5N1","volume":"27","author":"Adar","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.jaut.2014.07.005_bib61","unstructured":"www.BiondVax.com."},{"key":"10.1016\/j.jaut.2014.07.005_bib62","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/nm.2612","article-title":"Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans","volume":"18","author":"Wilkinson","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.jaut.2014.07.005_bib63","unstructured":"Atsmon J, Caraco Y, Ziv-Sefer S, Shaikevich D, Abramov E, Volokhov I, et\u00a0al. Priming by a novel universal influenza vaccine (multimeric-001) \u2013 a gateway for improving immune response in the elderly population. Vaccine, in press."},{"key":"10.1016\/j.jaut.2014.07.005_bib64","unstructured":"http:\/\/www.fda.gov\/downloads\/AdvisoryCommittees\/CommitteesMeetingMaterials\/BloodVaccinesandOtherBiologics\/VaccinesandRelatedBiologicalProductsAdvisoryCommittee\/UCM330392.pptx."},{"key":"10.1016\/j.jaut.2014.07.005_bib65","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jaut.2012.05.004","article-title":"Pierre Youinou: when intuition and determination meet autoimmunity","volume":"39","author":"Jamin","year":"2012","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.jaut.2014.07.005_bib66","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jaut.2013.05.003","article-title":"Rethinking mechanisms of autoimmune pathogenesis","volume":"45","author":"Pillai","year":"2013","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.jaut.2014.07.005_bib67","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2013.07.006","article-title":"Abul Abbas: an epitome of scholarship","volume":"45","author":"Gershwin","year":"2013","journal-title":"J\u00a0Autoimmun"}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841114001188?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841114001188?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T08:09:11Z","timestamp":1760256551000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841114001188"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":67,"alternative-id":["S0896841114001188"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2014.07.005","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epitope-based approaches to a universal influenza vaccine","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2014.07.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}